PT2523701T - Composições de hidrogel estáveis incluindo aditivos - Google Patents
Composições de hidrogel estáveis incluindo aditivosInfo
- Publication number
- PT2523701T PT2523701T PT117091843T PT11709184T PT2523701T PT 2523701 T PT2523701 T PT 2523701T PT 117091843 T PT117091843 T PT 117091843T PT 11709184 T PT11709184 T PT 11709184T PT 2523701 T PT2523701 T PT 2523701T
- Authority
- PT
- Portugal
- Prior art keywords
- compositions including
- hydrogel compositions
- including additives
- stable hydrogel
- stable
- Prior art date
Links
- 239000000654 additive Substances 0.000 title 1
- 239000000017 hydrogel Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/687,048 US20110171286A1 (en) | 2010-01-13 | 2010-01-13 | Hyaluronic acid compositions for dermatological use |
US12/714,377 US20110172180A1 (en) | 2010-01-13 | 2010-02-26 | Heat stable hyaluronic acid compositions for dermatological use |
US12/956,542 US20110171310A1 (en) | 2010-01-13 | 2010-11-30 | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2523701T true PT2523701T (pt) | 2016-12-20 |
Family
ID=44041744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT117091843T PT2523701T (pt) | 2010-01-13 | 2011-01-13 | Composições de hidrogel estáveis incluindo aditivos |
Country Status (10)
Country | Link |
---|---|
US (1) | US20110171310A1 (pt) |
EP (5) | EP2959923B1 (pt) |
JP (5) | JP5788412B2 (pt) |
KR (4) | KR101830591B1 (pt) |
AU (1) | AU2011206389B2 (pt) |
CA (2) | CA2905371C (pt) |
ES (4) | ES2614434T3 (pt) |
HK (1) | HK1219240A1 (pt) |
PT (1) | PT2523701T (pt) |
WO (1) | WO2011086458A1 (pt) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5722217B2 (ja) | 2008-09-02 | 2015-05-20 | アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエAllergan Holdings France S.A.S. | ヒアルロン酸および/またはその誘導体の糸、その作製方法、ならびにその使用 |
WO2010136585A2 (en) * | 2009-05-29 | 2010-12-02 | Galderma Research & Development | Combination of adrenergic receptor agonist -1 or -2, preferably brimonidine with fillers, preferablyhyaluronic acid |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
CA2794254C (en) | 2010-03-22 | 2018-09-04 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8455436B2 (en) | 2010-12-28 | 2013-06-04 | Depuy Mitek, Llc | Compositions and methods for treating joints |
US8398611B2 (en) | 2010-12-28 | 2013-03-19 | Depuy Mitek, Inc. | Compositions and methods for treating joints |
US8524662B2 (en) | 2010-12-28 | 2013-09-03 | Depuy Mitek, Llc | Compositions and methods for treating joints |
EP3682911A1 (en) * | 2011-01-13 | 2020-07-22 | Allergan, Inc. | Stable hydrogel compositions including additives |
EP2484387A1 (en) | 2011-02-03 | 2012-08-08 | Q-Med AB | Hyaluronic acid composition |
CN103702659B (zh) | 2011-06-03 | 2016-12-21 | 阿勒根公司 | 包括抗氧化剂的皮肤填充剂组合物 |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
US8623839B2 (en) | 2011-06-30 | 2014-01-07 | Depuy Mitek, Llc | Compositions and methods for stabilized polysaccharide formulations |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
US20130101547A1 (en) | 2011-10-19 | 2013-04-25 | Allergan, Inc. | Thermoresponsive compositions for dermatological use and methods thereof |
US9283217B2 (en) | 2011-11-10 | 2016-03-15 | Allergan, Inc. | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
US11116841B2 (en) | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
US20130281913A1 (en) | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
FR2991876B1 (fr) | 2012-06-13 | 2014-11-21 | Vivacy Lab | Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate |
FR2994846B1 (fr) | 2012-08-29 | 2014-12-26 | Vivacy Lab | Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium |
US20140276354A1 (en) | 2013-03-14 | 2014-09-18 | Klox Technologies Inc. | Biophotonic materials and uses thereof |
BE1022012B1 (fr) * | 2013-04-26 | 2016-02-04 | Auriga International | Gel stable d'acide hyaluronique et d'une forme libre de vitamine c et/ou de l'un de ses sels |
US9011934B2 (en) | 2013-06-14 | 2015-04-21 | SatisPharma, LLC | Multi-purpose anti-itch treatment |
AU2014286868B2 (en) | 2013-07-03 | 2019-12-19 | Klox Technologies Inc. | Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds |
US9492474B2 (en) | 2013-07-10 | 2016-11-15 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
US9421198B2 (en) | 2013-07-30 | 2016-08-23 | Teoxane | Composition comprising hyaluronic acid and mepivacaine |
KR101459070B1 (ko) * | 2013-12-09 | 2014-11-17 | (주) 뉴메딕 | 지속성을 갖는 히알루론산 겔 조성물 |
AR099941A1 (es) | 2014-04-01 | 2016-08-31 | Klox Tech Inc | Composiciones para relleno de tejido y métodos de uso |
KR102232928B1 (ko) * | 2014-08-12 | 2021-03-25 | 주식회사 엘지생활건강 | 시네프린 또는 이의 약학적으로 허용가능한 염을 포함하는 피부 미백, 탄력, 주름개선, 또는 보습용 화장료 또는 약학 조성물 |
US10722444B2 (en) * | 2014-09-30 | 2020-07-28 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
US9452178B1 (en) | 2014-10-22 | 2016-09-27 | SatisPharma, LLC | Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations |
US11421349B2 (en) | 2014-10-31 | 2022-08-23 | Klox Technologies Inc. | Photoactivatable fibers and fabric media |
US9682099B2 (en) | 2015-01-20 | 2017-06-20 | DePuy Synthes Products, Inc. | Compositions and methods for treating joints |
WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
US10004824B2 (en) | 2015-05-11 | 2018-06-26 | Laboratoires Vivacy | Compositions comprising at least one polyol and at least one anesthetic |
FR3036035B1 (fr) * | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
GB201508024D0 (en) * | 2015-05-11 | 2015-06-24 | Haemostatix Ltd | Haemostatic compositions |
PL3352766T3 (pl) * | 2015-09-24 | 2021-08-02 | Matrix Biology Institute | Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia |
FR3063649B1 (fr) * | 2017-03-07 | 2021-05-21 | Laboratoire De Rhumatologie Appliquee | Nouvelle solution visco-elastique et son utilisation en rhumatologie |
MX2019011873A (es) * | 2017-04-04 | 2019-11-21 | Anti Plasmin Tech Llc | Composiciones y metodos para mejorar un tratamiento medico no quirurgico. |
KR102202188B1 (ko) * | 2017-07-26 | 2021-01-13 | 주식회사 파이안바이오테크놀로지 | 고분자 히알루론산의 체내 지속성 향상용 조성물 및 이를 포함하는 주사용 피부 필러 조성물 |
MX2020002697A (es) * | 2017-09-12 | 2020-09-09 | Shilpa Medicare Ltd | Pulverizador de acido tranexamico para la artroplastia de rodilla. |
EP4309686A3 (en) | 2017-10-19 | 2024-02-07 | LifeCell Corporation | Flowable acellular tissue matrix products and methods of production |
US11246994B2 (en) * | 2017-10-19 | 2022-02-15 | Lifecell Corporation | Methods for introduction of flowable acellular tissue matrix products into a hand |
KR102008667B1 (ko) | 2017-11-02 | 2019-08-08 | 주식회사 엑소코바이오 | 안정화된 엑소좀의 필러 조성물 |
KR20190051434A (ko) | 2017-11-07 | 2019-05-15 | 주식회사 엑소코바이오 | 신규한 히알루론산 기반의 필러 조성물 및 이의 응용 |
WO2019121688A1 (en) | 2017-12-22 | 2019-06-27 | Nestlé Skin Health Sa | Injectable gel product |
CN110721341A (zh) * | 2018-07-17 | 2020-01-24 | 上海美白臻生物科技有限公司 | 一种长效型玻尿酸制备工艺 |
KR20200046649A (ko) | 2018-10-25 | 2020-05-07 | (주)뉴크레이티브랩 | 혼합상 히알루론산 제조방법 |
KR102187439B1 (ko) * | 2019-01-30 | 2020-12-07 | 주식회사 라파스 | 마이크로니들 패취를 이용한 최소 침습적 피부 생체 검사 방법 |
WO2021051080A1 (en) * | 2019-09-13 | 2021-03-18 | University Of Utah Research Foundation | Opioid independent surgical anesthetic |
IT201900024208A1 (it) * | 2019-12-17 | 2021-06-17 | Altergon Sa | Miscele iniettabili di acido ialuronico per uso in dermoestetica |
US11058640B1 (en) | 2020-04-07 | 2021-07-13 | Amc Group, Llc | Hyaluronate compositions and soft tissue fillers |
WO2021261967A1 (ko) | 2020-06-26 | 2021-12-30 | 주식회사 엘지에너지솔루션 | 리튬이차전지용 세퍼레이터 및 이를 포함하는 리튬이차전지 |
CA3188208A1 (en) * | 2020-08-10 | 2022-02-17 | Yewoo LEE | Delivery of cells and tissues with self-assembling peptide hydrogel materials |
WO2022035779A1 (en) * | 2020-08-10 | 2022-02-17 | Gel4Med, Inc. | Self-assembling amphiphilic peptide hydrogels |
TWI805175B (zh) * | 2021-01-07 | 2023-06-11 | 南韓商Lg化學股份有限公司 | 使用交聯劑和多元醇交聯之交聯的玻尿酸水凝膠以及含彼的填充物、彼之製法、及預填充之注射器 |
KR102385695B1 (ko) * | 2021-04-15 | 2022-04-12 | 남기준 | 세미-아이피엔 구조를 이루는 연조직 수복 및 확대를 위한 신규한 히알루론-복합 아미노 하이드로 겔 조성물 및 이의 용도 |
KR102640893B1 (ko) * | 2021-11-12 | 2024-02-27 | 주식회사 유영제약 | 히알루론산 가교물을 포함하는 조성물의 제조방법 |
WO2023148619A1 (en) | 2022-02-01 | 2023-08-10 | Galderma Holding SA | Methods of producing crosslinked hyaluronic acid hydrogels |
KR102527411B1 (ko) * | 2022-02-08 | 2023-04-28 | 영남이공대학교 산학협력단 | 습윤 밴드용 조성물, 상기 습윤밴드 및 이의 제조방법 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4838158B1 (pt) * | 1970-10-05 | 1973-11-15 | ||
US5137723A (en) * | 1989-05-19 | 1992-08-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | α-Glycosyl-L-ascorbic acid, and its preparation and uses |
JP2832848B2 (ja) * | 1989-10-21 | 1998-12-09 | 株式会社林原生物化学研究所 | 結晶2―O―α―D―グルコピラノシル―L―アスコルビン酸とその製造方法並びに用途 |
IT1260154B (it) * | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn) |
IT1277707B1 (it) * | 1995-12-22 | 1997-11-11 | Chemedica Sa | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
US6653462B2 (en) * | 1998-05-29 | 2003-11-25 | Applera Corporation | Nucleotide compounds including a rigid linker |
FR2780730B1 (fr) * | 1998-07-01 | 2000-10-13 | Corneal Ind | Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique |
JP2001192336A (ja) * | 2000-01-11 | 2001-07-17 | Hironori Yamamoto | 高粘性物質を用いた内視鏡的粘膜切除術 |
FR2811996B1 (fr) * | 2000-07-19 | 2003-08-08 | Corneal Ind | Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations |
AU2003206922A1 (en) | 2003-02-19 | 2004-09-09 | Aventis Pharmaceuticals Holdings Inc. | Composition and method for intradermal soft tissue augmentation |
FR2861734B1 (fr) * | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
AU2003901834A0 (en) * | 2003-04-17 | 2003-05-01 | Clearcoll Pty Ltd | Cross-linked polysaccharide compositions |
US20090148527A1 (en) * | 2007-12-07 | 2009-06-11 | Robinson Michael R | Intraocular formulation |
US8124120B2 (en) * | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
US20050281880A1 (en) * | 2004-05-20 | 2005-12-22 | Wei Wang | Methods for making injectable polymer hydrogels |
WO2006020994A2 (en) * | 2004-08-13 | 2006-02-23 | Angiotech International Ag | Compositions and methods using hyaluronic acid and hyluronidase inhibitors |
FR2878444B1 (fr) | 2004-11-30 | 2008-04-25 | Corneal Ind Soc Par Actions Si | Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations |
FR2894827B1 (fr) * | 2005-12-21 | 2010-10-29 | Galderma Res & Dev | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations |
FR2909560B1 (fr) * | 2006-12-06 | 2012-12-28 | Fabre Pierre Dermo Cosmetique | Gel d'acide hyaluronique pour injection intradermique |
WO2008098019A2 (en) * | 2007-02-05 | 2008-08-14 | Carbylan Biosurgery, Inc. | Polymer formulations for delivery of bioactive agents |
WO2008147817A2 (en) * | 2007-05-23 | 2008-12-04 | Allergan, Inc. | Coated hyaluronic acid particles |
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
US8697044B2 (en) * | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
US9161970B2 (en) * | 2007-12-12 | 2015-10-20 | Allergan, Inc. | Dermal filler |
EP2219679A1 (en) * | 2007-12-21 | 2010-08-25 | Encecor AB | Cross-linked hydrogel containing an active substance |
US8450475B2 (en) * | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
FR2938187B1 (fr) * | 2008-11-07 | 2012-08-17 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
JP2010202522A (ja) * | 2009-02-27 | 2010-09-16 | Shiseido Co Ltd | 耐塩性増粘剤及びそれを配合した化粧料 |
WO2010136585A2 (en) * | 2009-05-29 | 2010-12-02 | Galderma Research & Development | Combination of adrenergic receptor agonist -1 or -2, preferably brimonidine with fillers, preferablyhyaluronic acid |
EP2484387A1 (en) * | 2011-02-03 | 2012-08-08 | Q-Med AB | Hyaluronic acid composition |
-
2010
- 2010-11-30 US US12/956,542 patent/US20110171310A1/en not_active Abandoned
-
2011
- 2011-01-13 JP JP2012548497A patent/JP5788412B2/ja not_active Expired - Fee Related
- 2011-01-13 WO PCT/IB2011/000052 patent/WO2011086458A1/en active Application Filing
- 2011-01-13 PT PT117091843T patent/PT2523701T/pt unknown
- 2011-01-13 EP EP15178823.9A patent/EP2959923B1/en active Active
- 2011-01-13 CA CA2905371A patent/CA2905371C/en active Active
- 2011-01-13 EP EP21166261.4A patent/EP3862029A1/en not_active Withdrawn
- 2011-01-13 EP EP18206974.0A patent/EP3511028B1/en active Active
- 2011-01-13 EP EP11709184.3A patent/EP2523701B1/en active Active
- 2011-01-13 ES ES11709184.3T patent/ES2614434T3/es active Active
- 2011-01-13 ES ES15178823.9T patent/ES2613528T3/es active Active
- 2011-01-13 AU AU2011206389A patent/AU2011206389B2/en not_active Ceased
- 2011-01-13 ES ES16191450T patent/ES2716396T3/es active Active
- 2011-01-13 CA CA2786968A patent/CA2786968C/en active Active
- 2011-01-13 KR KR1020177022010A patent/KR101830591B1/ko active IP Right Grant
- 2011-01-13 EP EP16191450.2A patent/EP3138585B1/en active Active
- 2011-01-13 KR KR1020127021058A patent/KR101768733B1/ko active IP Right Grant
-
2012
- 2012-01-13 KR KR1020187025113A patent/KR102127060B1/ko active IP Right Grant
- 2012-01-13 ES ES12703634T patent/ES2805329T3/es active Active
- 2012-01-13 KR KR1020207017671A patent/KR20200078672A/ko active IP Right Grant
-
2015
- 2015-07-29 JP JP2015149880A patent/JP5960894B2/ja not_active Expired - Fee Related
-
2016
- 2016-06-23 JP JP2016124712A patent/JP6208293B2/ja not_active Expired - Fee Related
- 2016-06-23 HK HK16107286.0A patent/HK1219240A1/zh not_active IP Right Cessation
-
2017
- 2017-09-06 JP JP2017171396A patent/JP6509979B2/ja not_active Expired - Fee Related
-
2019
- 2019-04-03 JP JP2019071516A patent/JP2019131586A/ja not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1219240A1 (zh) | 包含添加劑的穩定水凝膠組合物 | |
HK1243746A1 (zh) | 組合物 | |
HRP20181658T1 (hr) | Kruti pripravci | |
IL221833A (en) | Solid ensembles | |
GB201009549D0 (en) | Compositions | |
EP2546324A4 (en) | LUBRICANT COMPOSITION | |
EP2522709A4 (en) | LUBRICANT COMPOSITION | |
GB201119596D0 (en) | Improved compositions | |
GB201009546D0 (en) | Compositions | |
GB201010954D0 (en) | Compositions | |
EP2522710A4 (en) | LUBRICANT COMPOSITION | |
GB201002861D0 (en) | Compositions | |
EP2566453A4 (en) | NOVEL OPHTHALMIC COMPOSITIONS | |
EP2625231A4 (en) | INK PRESERVATIVE COMPOSITIONS | |
EP2636724A4 (en) | LUBRICANT COMPOSITION | |
EP2605654A4 (en) | ANTIMICROBIAL COMPOSITIONS | |
IL225952A0 (en) | preparations@rokkhot | |
GB201014591D0 (en) | Compositions | |
EP2548939A4 (en) | LUBRICANT COMPOSITION | |
GB201007790D0 (en) | Compositions | |
EP2535397A4 (en) | LUBRICANT ADDITIVE COMPOSITION | |
GB201019606D0 (en) | Compositions | |
GB201008043D0 (en) | Compositions | |
GB201012508D0 (en) | Compositions | |
GB201012588D0 (en) | Compositions |